- Home
- HAFC vs RZLT Comparison
HAFC vs RZLT Comparison
Compare HAFC & RZLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HAFC
- RZLT
- Stock Information
- Founded
- HAFC 1982
- RZLT 2010
- Country
- HAFC United States
- RZLT United States
- Employees
- HAFC N/A
- RZLT N/A
- Industry
- HAFC Major Banks
- RZLT Biotechnology: Pharmaceutical Preparations
- Sector
- HAFC Finance
- RZLT Health Care
- Exchange
- HAFC Nasdaq
- RZLT Nasdaq
- Market Cap
- HAFC 758.9M
- RZLT 713.4M
- IPO Year
- HAFC 1996
- RZLT N/A
- Fundamental
- Price
- HAFC $24.95
- RZLT $8.87
- Analyst Decision
- HAFC Buy
- RZLT Strong Buy
- Analyst Count
- HAFC 6
- RZLT 6
- Target Price
- HAFC $26.00
- RZLT $14.50
- AVG Volume (30 Days)
- HAFC 139.8K
- RZLT 1.5M
- Earning Date
- HAFC 10-21-2025
- RZLT 11-06-2025
- Dividend Yield
- HAFC 4.31%
- RZLT N/A
- EPS Growth
- HAFC N/A
- RZLT N/A
- EPS
- HAFC 2.16
- RZLT N/A
- Revenue
- HAFC $233,739,000.00
- RZLT N/A
- Revenue This Year
- HAFC $17.24
- RZLT N/A
- Revenue Next Year
- HAFC $7.86
- RZLT N/A
- P/E Ratio
- HAFC $11.61
- RZLT N/A
- Revenue Growth
- HAFC N/A
- RZLT N/A
- 52 Week Low
- HAFC $18.19
- RZLT $2.22
- 52 Week High
- HAFC $27.59
- RZLT $9.72
- Technical
- Relative Strength Index (RSI)
- HAFC 54.02
- RZLT 61.82
- Support Level
- HAFC $24.55
- RZLT $8.97
- Resistance Level
- HAFC $25.36
- RZLT $9.72
- Average True Range (ATR)
- HAFC 0.54
- RZLT 0.61
- MACD
- HAFC -0.03
- RZLT -0.04
- Stochastic Oscillator
- HAFC 57.93
- RZLT 66.44
About HAFC Hanmi Financial Corporation
Hanmi Financial Corp is a Los Angeles-based bank that caters to Korean-Americans and other multi-ethnic communities across California, Colorado, Georgia, Illinois, New Jersey, New York, Texas, Virginia, and Washington. The bank mainly focuses on small businesses and commercial and real estate loans. It also offers a variety of international finance and trade services and products, including letters of credit, import financing, and export financing. The Bank's revenues are derived from interest and fees on loans, interest, and dividends on the securities portfolio, service charges on deposit accounts, and sales of SBA loans.
About RZLT Rezolute Inc. (NV)
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402.